Powdered vaccine needing no refrigeration passes first human trials

A new-generation powdered vaccine that does not require refrigeration has passed its first human trials successfully. The tested preparation is a combined vaccine against tetanus and diphtheria. The breakthrough could revolutionise vaccine distribution, particularly in countries with limited cold-chain infrastructure.